bioRxivCell Biology
Pyruvate kinase controls signal strength in the insulin secretory pathway
S. L. Lewandowski, R. L. Cardone, H. R. Foster, T. Ho, E. Potapenko, C. Poudel, H. R. VanDeusen, T. C. Alves, X. Zhao, M. E. Capozzi, I. Jahan, C. S. Nunemaker, J. E. Campbell, C. J. Thomas, R. G. Kibbey, M. J. Merrins
Abstract
Pancreatic {beta}-cells couple nutrient metabolism with appropriate insulin secretion. Here, we show that pyruvate kinase (PK), which converts ADP and phosphoenolpyruvate (PEP) into ATP and pyruvate, underlies {beta}-cell sensing of both glycolytic and mitochondrial fuels. PK present at the plasma membrane is sufficient to close KATP channels and initiate calcium influx. Small-molecule PK activators increase {beta}-cell oscillation frequency and potently amplify insulin secretion. By cyclically depriving mitochondria of ADP, PK restricts oxidative phosphorylation in favor of the mitochondrial PEP cycle with no net impact on glucose oxidation. Our findings support a compartmentalized model of {beta}-cell metabolism in which PK locally generates the ATP/ADP threshold required for insulin secretion, and identify a potential therapeutic route for diabetes based on PK activation that would not be predicted by the {beta}-cell consensus model. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=164 HEIGHT=200 SRC="FIGDIR/small/907790v1_ufig1.gif" ALT="Figure 1"> View larger version (45K): org.highwire.dtl.DTLVardef@1f6503forg.highwire.dtl.DTLVardef@e9393org.highwire.dtl.DTLVardef@fab08borg.highwire.dtl.DTLVardef@5c7c55_HPS_FORMAT_FIGEXP M_FIG C_FIG The consensus model for {beta}-cell glucose sensing supports a dominant role for OxPhos. This model doesnt fully explain the observed metabolic and electrophysiologic oscillations associated with glucose-stimulated insulin secretion. Lewandowski et al. challenge this model by mechanistically connecting the anaplerotic PEP cycle to the electrically silent triggering phase, and OxPhos to the electrically active secretory phase. Here, the allosteric recruitment of pyruvate kinase directs metabolic traffic between the two cycles and identifies potential therapeutic strategies for diabetes based on pharmacologic pyruvate kinase activation. HIGHLIGHTSO_LICompartmentalized pyruvate kinase (PK) activity underlies {beta}-cell fuel sensing C_LIO_LIMembrane-associated PK closes KATP channels and controls calcium influx C_LIO_LIBy lowering ADP, PK toggles mitochondria between OxPhos and PEP biosynthesis C_LIO_LIPharmacologic PK activation increases oscillatory frequency and amplifies secretion C_LI
- organism: mouse
- assay: metabolomics
- assay: electrophysiology
- research focus: cell signaling & trafficking
- research focus: cancer & tumor microenvironment
- research focus: drug response / drug discovery
- approach: experimental assay
- approach: biophysical modeling
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The isoforms of pyruvate kinase act as nutrient sensors for the β-cell KATP channel
H. R. Foster, T. Ho, … M. J. Merrins·bioRxiv·Feb 9, 2022
- Pyruvate kinase modulates the link between β-cell fructose metabolism and insulin secretion
Naoya Murao, Risa Morikawa, … Atsushi Suzuki·The FASEB JournalPeer-reviewed·Mar 28, 2025
- Pharmacologic activation of the mitochondrial phosphoenolpyruvate cycleenhances islet function in vivo
A. Abulizi, R. Stark, … R. G. Kibbey·bioRxiv·Feb 13, 2020
- Kinetic modelling of β-cell metabolism reveals control points in the insulin-regulating pyruvate cycling pathways
Rahul Rahul, Adam R. Stinchcombe, … Brian Ingalls·IET Systems BiologyPeer-reviewed·Nov 8, 2023
- A plasma membrane-associated glycolytic metabolon is functionally coupled to KATP channels in pancreatic α and β cells from humans and mice
T. Ho, E. Potapenko, … M. J. Merrins·bioRxiv·Oct 6, 2022
- AKAP79/150 coordinates leptin-induced PKA activation to regulate KATP channel trafficking in pancreatic β-cells
V. Cochrane, Z. Yang, … S.-L. Shyng·bioRxiv·Nov 25, 2020